Clinical Impact of Denovo or Recurrent Donor Specific Antibodies in the First Year Post Kidney Transplant in Patients on Early Steroid Withdrawal Immunosupression Regimen.

被引:0
|
作者
Adebiyi, O. [1 ]
Taber, T. [1 ]
Goggins, W. [1 ]
Mishler, D. [1 ]
Yaqub, M. [1 ]
Sharfuddin, A. [1 ]
机构
[1] Indiana Univ Hlth, Div Renal Dis & Hypertens, Indianapolis, IN USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
433
引用
收藏
页码:414 / 414
页数:1
相关论文
共 49 条
  • [1] Pre Transplant Donor Specific Antibodies and Clinical Outcomes in Kidney Transplant Recipient on Steroid Free Maintenance Immunosupression Regimen
    Adebiyi, O.
    Sharfuddin, A.
    Yaqub, M.
    Hussain, S.
    Mishler, D.
    Sharfuddin, A.
    Goggins, W.
    Taber, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 737 - 737
  • [2] Clinical Impact of Strength and Class of Pre transplant Donor Specific Antibody on Kidney Transplant Recipient Receiving Steroid Free Maintenance Immunosupression Regimen
    Adebiyi, O.
    Simo, O.
    Hussain, S.
    Mishler, D.
    Goggins, W.
    Taber, T.
    Sharfuddin, A.
    Yaqub, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 734 - 734
  • [3] Development of Denovo DSA after One Year Post Kidney Transplant and Clinical Outcomes in Patient on Steroid Free Immunosupression.
    Sharfuddin, A.
    Yaqub, M.
    Mishler, D.
    Goggins, W.
    Taber, T.
    Adebiyi, O.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 416 - 416
  • [4] Incidence of De Novo Donor Specific Antibodies After Early Steroid Withdrawal in Kidney Transplant Recipients.
    Majmundar, D.
    Karhadkar, S.
    Diamond, A.
    Au, J.
    Ruggia-Check, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 803 - 803
  • [5] TREATMENT OF POST-TRANSPLANT DENOVO HLA DONOR SPECIFIC ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENT IN THE ABSENCE OF REJECTION
    Mujtaba, Muhammad A.
    Gamilla-Crudo, Ann
    Aleter, Omer
    Noriega, Ramon
    Ramirez, Regina
    [J]. HUMAN IMMUNOLOGY, 2017, 78 : 180 - 180
  • [6] Post transplant donor specific antibodies in steroid resistant kidney rejection. A preliminary study
    Martorell, J
    Crespo, M
    Sole, M
    Lozano, M
    Esforzado, N
    Mila, J
    Oppenheimer, F
    Vives, J
    [J]. GENES AND IMMUNITY, 2003, 4 : S54 - S54
  • [7] Incidence of Donor-Specific Antibodies in Kidney-Transplant Patients Receiving an Everolimus-Based, Calcineurin Inhibitor-Free Immunosuppressive Regimen.
    Kamar, N.
    Fort, M.
    Cardeau-Desangles, I.
    Congy, N.
    Esposito, L.
    Guitard, J.
    Rostaing, L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 409 - 410
  • [8] NO OCCURRENCE OF DE NOVO DONOR-SPECIFIC HLA ANTIBODIES IN PATIENTS WITH EARLY STEROID WITHDRAWAL IN A 5-YEAR PROSPECTIVE STUDY
    Delgado, Julio C.
    Fuller, Anne
    Osawa, Mikki
    Smith, Lonnie
    Pavlov, Igor
    Hammad, Mohammed J.
    Terasaki, Paul I.
    Shihab, Fuad
    Eckels, David D.
    [J]. HUMAN IMMUNOLOGY, 2008, 69 : S29 - S29
  • [9] No occurrence of de novo donor-specific HLA antibodies in patients with early steroid withdrawal in a 5-year prospective study
    Delgado, J. C.
    Fuller, A.
    Ozawa, M.
    Smith, L.
    Pavlov, I.
    Hammad, M.
    Terasaki, P. I.
    Shihab, F.
    Eckels, D. D.
    [J]. TISSUE ANTIGENS, 2008, 72 (03): : 259 - 259
  • [10] A prospective multicenter national study to assess the feasibility and benefits of steroid withdrawal in kidney transplant patients under a mycophenolate mofetil and tacrolimus-based regimen.
    Alarcon, A
    Del Castillo, D
    Gentil, MA
    Gomez, P
    Capdevilla, L
    Romero, R
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 224 - 224